SILBER ALLAN C 5
5 · POINT Biopharma Global Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 5
SILBER ALLAN C
Director
Transactions
- Award
Common Stock
2021-06-30+313,884→ 313,884 total(indirect: By Spouse) - Other
Common Stock
2021-06-30−23,309→ 514,778 total(indirect: By Trust)
Holdings
- 4,218,605
Common Stock
- 4,035,655(indirect: Silber Holdings, Inc.)
Common Stock
- 71,744(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]On June 30, 2021, POINT Biopharma Global Inc. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, merged with and into POINT Biopharma Inc. ("Old POINT"). At the effective time of the Business Combination, each share of Old POINT outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person's spouse received the reported shares of the Issuer's Common Stock in consideration for the equity securities of Old POINT held by the Reporting Person's spouse prior to the Business Combination. These shares held by the Reporting Person's spouse were inadvertently omitted from the Form 4 filed by the Reporting Person on June 30, 2021.
- [F2]On June 30, 2021, the Reporting Person, as trustee, distributed 23,309 shares of the Issuer's Common Stock held pursuant to a trust to certain beneficiaries of that trust. This disposition was inadvertently omitted from the Form 4 filed by the Reporting Person on June 30, 2021.
- [F3]Held in a trust for which the Reporting Person is the trustee.
- [F4]Silber Holdings, Inc is a corporation controlled by the Reporting Person.
- [F5]Anglian Holdings, LLC is a limited liability company solely owned by the Reporting Person.